Janux Therapeutics Inc (JANX)

R&D to Revenue

301.88%

Quarterly · Period ending:

JANX logo

JANX R&D to Revenue

Latest reported301.88%
JANX Quarterly R&D/Revenue (0.00% → 301.88%)
High-resolution chart · PNG

JANX r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Janux Therapeutics Inc R&D to Revenue — Quarterly
Period endingR&D to Revenue
301.8798%
718.2695%
0%
346.29%
0%
0%
0%
4,240.0911%
167.4497%
1,123.8019%
497.3994%
472.4672%
1,411.9205%
774.6582%
542.4956%
757.6944%
595.6025%
640.9062%
691.151%
725.2804%
982.7801%
506.5789%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.